Impact of lymphadenectomy rates in the quality assurance program in early ovarian cancer of the AGO Study Group: real-world observations

Objectives - The German quality assurance program (QS-Ovar) representatively documents treatment and survival for patients with the initial diagnosis of primary ovarian cancer in the third quarters of 2004, 2008, 2012, 2016, and 2021. We evaluate lymphadenectomy (LNE) rates in dependence on histolog...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Wimberger, Pauline (VerfasserIn) , Pfisterer, Jacobus (VerfasserIn) , du Bois, Andreas (VerfasserIn) , Hilpert, Felix (VerfasserIn) , Kerkmann, Markus (VerfasserIn) , Sehouli, Jalid (VerfasserIn) , Mahner, Sven (VerfasserIn) , de Gregorio, Nikolaus (VerfasserIn) , Hanker, Lars (VerfasserIn) , Heitz, Florian (VerfasserIn) , Marmé, Frederik (VerfasserIn) , Wölber, Linn (VerfasserIn) , Holtmann, Laura (VerfasserIn) , Elser, Gabriele (VerfasserIn) , Harter, Philipp (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: June 2025
In: European journal of surgical oncology
Year: 2025, Jahrgang: 51, Heft: 6, Pages: 1-10
ISSN:1532-2157
DOI:10.1016/j.ejso.2025.109696
Online-Zugang:Verlag, kostenfrei, Volltext: https://doi.org/10.1016/j.ejso.2025.109696
Verlag, kostenfrei, Volltext: https://www.sciencedirect.com/science/article/pii/S0748798325001246
Volltext
Verfasserangaben:Pauline Wimberger, Jacobus Pfisterer, Andreas du Bois, Felix Hilpert, Markus Kerkmann, Jalid Sehouli, Sven Mahner, Nikolaus de Gregorio, Lars Hanker, Florian Heitz, Frederik Marmé, Linn Wölber, Laura Holtmann, Gabriele Elser, Philipp Harter, for the AGO Study Group

MARC

LEADER 00000caa a2200000 c 4500
001 1933369833
003 DE-627
005 20250913141845.0
007 cr uuu---uuuuu
008 250818s2025 xx |||||o 00| ||eng c
024 7 |a 10.1016/j.ejso.2025.109696  |2 doi 
035 |a (DE-627)1933369833 
035 |a (DE-599)KXP1933369833 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Wimberger, Pauline  |d 1971-  |e VerfasserIn  |0 (DE-588)121614859  |0 (DE-627)705574733  |0 (DE-576)292800061  |4 aut 
245 1 0 |a Impact of lymphadenectomy rates in the quality assurance program in early ovarian cancer of the AGO Study Group  |b real-world observations  |c Pauline Wimberger, Jacobus Pfisterer, Andreas du Bois, Felix Hilpert, Markus Kerkmann, Jalid Sehouli, Sven Mahner, Nikolaus de Gregorio, Lars Hanker, Florian Heitz, Frederik Marmé, Linn Wölber, Laura Holtmann, Gabriele Elser, Philipp Harter, for the AGO Study Group 
264 1 |c June 2025 
300 |b Illustrationen 
300 |a 10 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Online veröffentlicht: 15. Februar 2025, Artikelversion: 5. März 2025 
500 |a Gesehen am 18.08.2025 
520 |a Objectives - The German quality assurance program (QS-Ovar) representatively documents treatment and survival for patients with the initial diagnosis of primary ovarian cancer in the third quarters of 2004, 2008, 2012, 2016, and 2021. We evaluate lymphadenectomy (LNE) rates in dependence on histologic subtype and outcome for early ovarian cancer FIGO I. - Methods - Therapy quality was defined according to national guidelines. Surgical quality was categorized as “optimal“ (SUR+: maximum 1 surgical item missing), versus “suboptimal“ (SUR-); analogous categorization “optimal“ systemic treatment (CT+) and “suboptimal“ (CT-). - Results - Overall, 832 pts. (19.3 %) were diagnosed with FIGO I, of them 47.6 % with FIGO IC, 35.7 % had a high-grade serous subtype, 5.0 % low-grade serous, 6.9 % low-grade endometrioid, 18 % high-grade endometrioid, 11 % clear cell, and 18 % mucinous tumors. The optimal surgical standard increased from 21.1 % (2004) to 53.0 % (2012). Surgical quality has remained unchanged in 2021 with 53.8 % and SUR + -subgroup with 74.2 %. The rate of pelvic and para-aortic lymphadenectomy increased over time for high-grade serous and clear cell carcinoma and decreased for mucinous carcinoma. In 2021, 67.6 % had ≥25 resected lymph-nodes in high-grade serous, 46.2 % in low-grade serous, 52.2 % in high-grade endometrioid, 35.3 % in low-grade endometrioid, 74.1 % in clear cell and 35.7 % in mucinous tumors. In 2021, the SUR+/CT + -subgroup decreased to 62.9 % versus 69.2 % in 2016. Four-year-disease-free-survival was 86 % for SUR+/CT+, 78 % for SUR-/CT+, 68 % for SUR+/CT- and 57 % for SUR-/CT- (p < 0.001). - Conclusions - One therapy modality cannot replace another one. Although urgently required, quality of therapy has not improved in 2021. 
700 1 |a Pfisterer, Jacobus  |e VerfasserIn  |4 aut 
700 1 |a du Bois, Andreas  |e VerfasserIn  |4 aut 
700 1 |a Hilpert, Felix  |e VerfasserIn  |4 aut 
700 1 |a Kerkmann, Markus  |e VerfasserIn  |4 aut 
700 1 |a Sehouli, Jalid  |e VerfasserIn  |4 aut 
700 1 |a Mahner, Sven  |e VerfasserIn  |4 aut 
700 1 |a de Gregorio, Nikolaus  |e VerfasserIn  |4 aut 
700 1 |a Hanker, Lars  |e VerfasserIn  |4 aut 
700 1 |a Heitz, Florian  |e VerfasserIn  |4 aut 
700 1 |a Marmé, Frederik  |d 1974-  |e VerfasserIn  |0 (DE-588)132561972  |0 (DE-627)52394893X  |0 (DE-576)299226549  |4 aut 
700 1 |a Wölber, Linn  |e VerfasserIn  |4 aut 
700 1 |a Holtmann, Laura  |e VerfasserIn  |4 aut 
700 1 |a Elser, Gabriele  |e VerfasserIn  |4 aut 
700 1 |a Harter, Philipp  |e VerfasserIn  |4 aut 
773 0 8 |i Enthalten in  |t European journal of surgical oncology  |d Burlington, Mass. : Harcourt, 1995  |g 51(2025), 6, Artikel-ID 109696, Seite 1-10  |h Online-Ressource  |w (DE-627)320420361  |w (DE-600)2002481-2  |w (DE-576)103746862  |x 1532-2157  |7 nnas  |a Impact of lymphadenectomy rates in the quality assurance program in early ovarian cancer of the AGO Study Group real-world observations 
773 1 8 |g volume:51  |g year:2025  |g number:6  |g elocationid:109696  |g pages:1-10  |g extent:10  |a Impact of lymphadenectomy rates in the quality assurance program in early ovarian cancer of the AGO Study Group real-world observations 
856 4 0 |u https://doi.org/10.1016/j.ejso.2025.109696  |x Verlag  |x Resolving-System  |z kostenfrei  |3 Volltext 
856 4 0 |u https://www.sciencedirect.com/science/article/pii/S0748798325001246  |x Verlag  |z kostenfrei  |3 Volltext 
951 |a AR 
992 |a 20250818 
993 |a Article 
994 |a 2025 
998 |g 132561972  |a Marmé, Frederik  |m 132561972:Marmé, Frederik  |d 60000  |d 61300  |d 50000  |e 60000PM132561972  |e 61300PM132561972  |e 50000PM132561972  |k 0/60000/  |k 1/60000/61300/  |k 0/50000/  |p 11 
999 |a KXP-PPN1933369833  |e 4758596204 
BIB |a Y 
SER |a journal 
JSO |a {"relHost":[{"disp":"Impact of lymphadenectomy rates in the quality assurance program in early ovarian cancer of the AGO Study Group real-world observationsEuropean journal of surgical oncology","titleAlt":[{"title":"EJSO"}],"note":["Gesehen am 05.02.20"],"origin":[{"dateIssuedDisp":"1995-","publisherPlace":"Burlington, Mass.","publisher":"Harcourt","dateIssuedKey":"1995"}],"type":{"bibl":"periodical","media":"Online-Ressource"},"title":[{"title":"European journal of surgical oncology","title_sort":"European journal of surgical oncology"}],"part":{"issue":"6","year":"2025","text":"51(2025), 6, Artikel-ID 109696, Seite 1-10","pages":"1-10","extent":"10","volume":"51"},"language":["eng"],"physDesc":[{"extent":"Online-Ressource"}],"pubHistory":["Nachgewiesen 21.1995 -"],"recId":"320420361","id":{"issn":["1532-2157"],"eki":["320420361"],"zdb":["2002481-2"]}}],"id":{"eki":["1933369833"],"doi":["10.1016/j.ejso.2025.109696"]},"name":{"displayForm":["Pauline Wimberger, Jacobus Pfisterer, Andreas du Bois, Felix Hilpert, Markus Kerkmann, Jalid Sehouli, Sven Mahner, Nikolaus de Gregorio, Lars Hanker, Florian Heitz, Frederik Marmé, Linn Wölber, Laura Holtmann, Gabriele Elser, Philipp Harter, for the AGO Study Group"]},"physDesc":[{"noteIll":"Illustrationen","extent":"10 S."}],"recId":"1933369833","origin":[{"dateIssuedDisp":"June 2025","dateIssuedKey":"2025"}],"note":["Online veröffentlicht: 15. Februar 2025, Artikelversion: 5. März 2025","Gesehen am 18.08.2025"],"title":[{"title_sort":"Impact of lymphadenectomy rates in the quality assurance program in early ovarian cancer of the AGO Study Group","subtitle":"real-world observations","title":"Impact of lymphadenectomy rates in the quality assurance program in early ovarian cancer of the AGO Study Group"}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"language":["eng"],"person":[{"given":"Pauline","role":"aut","family":"Wimberger","display":"Wimberger, Pauline"},{"family":"Pfisterer","display":"Pfisterer, Jacobus","given":"Jacobus","role":"aut"},{"family":"du Bois","display":"du Bois, Andreas","given":"Andreas","role":"aut"},{"family":"Hilpert","display":"Hilpert, Felix","given":"Felix","role":"aut"},{"family":"Kerkmann","display":"Kerkmann, Markus","given":"Markus","role":"aut"},{"given":"Jalid","role":"aut","display":"Sehouli, Jalid","family":"Sehouli"},{"given":"Sven","role":"aut","display":"Mahner, Sven","family":"Mahner"},{"role":"aut","given":"Nikolaus","family":"de Gregorio","display":"de Gregorio, Nikolaus"},{"role":"aut","given":"Lars","family":"Hanker","display":"Hanker, Lars"},{"role":"aut","given":"Florian","display":"Heitz, Florian","family":"Heitz"},{"family":"Marmé","display":"Marmé, Frederik","given":"Frederik","role":"aut"},{"given":"Linn","role":"aut","family":"Wölber","display":"Wölber, Linn"},{"given":"Laura","role":"aut","display":"Holtmann, Laura","family":"Holtmann"},{"given":"Gabriele","role":"aut","display":"Elser, Gabriele","family":"Elser"},{"given":"Philipp","role":"aut","family":"Harter","display":"Harter, Philipp"}]} 
SRT |a WIMBERGERPIMPACTOFLY2025